1-(2-Nitrobenzenesulfonyl)-4-[5-(thiophen-2-yl)-1H-pyrazol-3-yl]piperidine

Catalog No. :
ACFIPR485
CAS No. :
1026099-77-3
Molecular Formula :
C18H18N4O4S2
Molecular Weight :
418.5

IUPAC Name:1-((2-nitrophenyl)sulfonyl)-4-(3-(thiophen-2-yl)-1H-pyrazol-5-yl)piperidine

1-(2-Nitrobenzenesulfonyl)-4-[5-(thiophen-2-yl)-1H-pyrazol-3-yl]piperidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$289.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(2-Nitrobenzenesulfonyl)-4-[5-(thiophen-2-yl)-1H-pyrazol-3-yl]piperidine
IUPAC Name1-((2-nitrophenyl)sulfonyl)-4-(3-(thiophen-2-yl)-1H-pyrazol-5-yl)piperidine
MDL No.MFCD05256352
Molecular FormulaC18H18N4O4S2
Molecular Weight418.5
SMILESO=S(N1CCC(C2=NNC(C3=CC=CS3)=C2)CC1)(C4=CC=CC=C4[N+]([O-])=O)=O
InChI KeyWRTCBBFDXKOHBD-UHFFFAOYSA-N
Synonym1-[(2-NITROPHENYL)SULFONYL]-4-[5-(2-THIENYL)-1H-PYRAZOL-3-YL]PIPERIDINE;1-(2-nitrobenzenesulfonyl)-4-[5-(thiophen-2-yl)-1H-pyrazol-3-yl]piperidine;Piperidine, 1-[(2-nitrophenyl)sulfonyl]-4-[5-(2-thienyl)-1H-pyrazol-3-yl]-
CAS No.1026099-77-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACFIPR485 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFIPR485 route product structure diagram
    ACFIPR4851026099-77-3
Inquiry

2. ACFIPR485 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFIPR485 route product structure diagram
    ACFIPR4851026099-77-3
Inquiry

Comments (0)